Milestone Pharmaceuticals Inc.

Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Milestone Pharmaceuticals Inc. (NASDAQ: MIST) resulting from allegations that Milestone may have issued materially misleading business information to the investing public.

If you purchased Milestone securities and would like to join the prospective action, please click “Join This Class Action.”

If you purchased Milestone securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

Details of investigation:

On December 26, 2023, before the market opened, Milestone Pharmaceuticals, Inc. announced that it had received a Refuse to File (“RTF”) letter from the U.S. Food and Drug Administration (“FDA”) for its recently submitted new drug application for its lead investigational product, Etripamil, a self-administered nasal spray for the treatment of paroxysmal supraventricular tachycardia. In the RTF, the FDA noted that Milestone had not provided the agency with sufficient information to permit substantive review, and sought additional information related to the timing of adverse events in Etripamil’s Phase 3 trial.

On this news, Milestone’s stock fell $0.89 per share, or 30.90%, to close at $1.99 per share on December 26, 2023.

Follow us on:
Company Name: Milestone Pharmaceuticals Inc.
Stock Symbol: MIST
Class Period: N/A
Court: N/A

Why Rosen Law

The Rosen Law Firm has been ranked among the top 4 law firms each year since 2013 for the number of successful securities class actions on behalf of investors. In 2019 alone, our firm recovered $438 million for investors.

Investors should carefully identify and select experienced counsel with a track record of success leading securities class actions. Often other firms issue press releases about class actions yet do not have comparable experience or resources.

Institutional Shareholders Services ranked the Rosen Law Firm # 1 for the number of securities class action recoveries in 2017.

The Rosen Law Firm represents investors throughout the globe. Our mission is to prosecute securities fraud class actions and protect shareholders’ rights.

Scroll to Top